|
|

Home > Healthcare > Pharmaceutical > Drug Products
Global Pharmaceuticals Industry Report
|

The Global Pharmaceuticals Industry Report
Plimsoll Publishing Ltd.
Do you know....
The top 7 best trading partners in the industry?
Which company has the highest sales growth?
Which companies have the highest levels of debt?
This report is an in-depth financial evaluation of the global Pharmaceuticals industry. Using the unique Plimsoll method of analysis, each of the top 500 global Pharmaceuticals Manufacturers is individually assessed and ranked against each other and compared to industry averages. Using the most up-to-date financial information available, the two-page analysis provides detailed financial analysis for each Pharmaceuticals manufacturer, including details of;
- Sales growth
- Trading stability
- Profitability
- Employee performance
- Level of debt
- Gearing ratio’s
- Creditor Exposure
- Performance ratio’s
- Overall financial rating
Results are shown in graphical, numeric and narrative forms, and all individual analysis are measured in both the company’s own currency, and USD ($) for ease of use. These individual analyses highlight a company’s success just as easily as it can emphasise its vulnerability.
Along with individual company information, this report also contains an assesment of the market, based on the companies analysed. This key information identifies;
- Best trading partners (based on commercial and financial strength)
- Sales growth (highest sales, growth rate, size of market based on the companies analysed, average growth)
- Profitability (Profit return on assets, pre-tax profit margins, industry average)
- Fastest growing companies (performance matrix)
Companies can change at an alarming rate in a very short space of time, so it is vital that you keep up-to-date with any changes to your market, and how those changes can affect you. This report can provide you with an in-depth look at your industry, highlight new market opportunities and provide important information to help develop accurate strategic business plans. Whether you wish to benchmark your own company’s results, study the industry in more depth or have a vast array of industry intelligence at your disposal, this report is the ideal resource.
|
Similar Products
• Snapshots US Pharmaceuticals 2009
Published Nov 2009 by Snapdata International Group
• Pharmaceutical Industry in the United States - Porter’s Five Forces Strategy Analysis
Published Nov 2009 by Aruvian's R'search
• Pharmaceutical Industry in Mexico
Published Nov 2009 by Aruvian's R'search
• Pharmaceuticals Industry Report
Published Nov 2009 by Plimsoll Publishing Ltd.
• Antipsychotics Market Forecast
Published Oct 2009 by Datamonitor
• Commercial Insight: Antidiabetics in Australia - Reimbursement status shapes novel classes
Published Oct 2009 by Datamonitor
• Prescription Drug Wholesaling in the US - Industry Risk Rating Report
Published Oct 2009 by IBISWorld
• Antidepressants Market Forecast
Published Oct 2009 by Datamonitor
• Snapshots Bulgaria Pharmaceuticals 2009
Published Oct 2009 by Snapdata International Group
• Snapshots Australia Pharmaceuticals 2009
Published Oct 2009 by Snapdata International Group
|
|
|
|